PBS and Non-PBS Medicines: Why Some of Our Range Isn't Subsidised
Reviewed by the Kamagra AUS Pharmacy Team on 10 October 2026 · Next review June 2027
Summary
Not every prescription medicine in Australia is subsidised — here's how the PBS actually works, and why medicines like generic ED treatments, pregabalin and carisoprodol often sit outside it.
On this page
If you've ever compared prices between two prescription medicines and wondered why one costs a few dollars and the other costs considerably more, the answer usually comes down to one thing: whether that medicine is listed on the Pharmaceutical Benefits Scheme (PBS). It isn't about quality, safety or how "real" a medicine is — plenty of registered, Schedule 4 Prescription Only medicines sit outside the PBS for reasons that have more to do with policy than pharmacology. Understanding how the scheme works makes it a lot easier to understand your own script.
What the PBS actually does
The PBS is the Australian Government scheme that subsidises the cost of a defined list of medicines, so patients pay a capped co-payment instead of the full manufacturer price. It's a genuinely valuable system, and it covers a huge portion of the prescriptions written in Australia every day. But it has never covered — and was never designed to cover — every medicine available on prescription. The PBS works from a specific, government-managed list (the Schedule of Pharmaceutical Benefits), and if a medicine isn't on that list, the pharmacy charges its normal retail price instead of the subsidised co-payment.
How a medicine gets onto that list
A medicine doesn't automatically qualify for PBS listing just because it's registered for supply in Australia. The manufacturer has to apply, and the independent Pharmaceutical Benefits Advisory Committee (PBAC) assesses that application against cost-effectiveness evidence — essentially, how the new medicine's benefit and cost compare with treatments already subsidised for the same condition. Some applications succeed. Others are knocked back, sometimes more than once, or are approved only for a narrow group of patients who meet specific clinical criteria (this is called a "restricted" listing). None of this reflects badly on a medicine that misses out — it simply means the economic case for public subsidy, as assessed by that process, wasn't made for the general population.
Why generic ED medicines are usually non-PBS
Generic sildenafil, tadalafil and vardenafil are registered Schedule 4 Prescription Only medicines used to treat erectile dysfunction. For the vast majority of men, medicines in this category sit outside the PBS entirely — they're treated as lifestyle medicines rather than medicines for a condition the scheme prioritises for general subsidy. There are narrow PBS listings for specific ED-related brands prescribed for particular circumstances (such as after certain pelvic surgery), but for most patients, ED medicines are bought at full retail price whether from a pharmacy or a service like ours. This is exactly why generic versions matter: they don't change the subsidy situation, but they do bring the retail price down considerably compared with the original branded product.
Why pregabalin and carisoprodol sit differently
Pregabalin brands have a mixed position — some strengths and brands hold general PBS listings for nerve pain and epilepsy, while others are only PBS-subsidised for narrower, specified conditions, and some brands or pack sizes aren't listed at all. Carisoprodol, a muscle relaxant, isn't PBS-listed and in Australia is generally accessed as a private prescription. In both cases, the same PBAC process applies: subsidy depends on the specific brand, strength, indication and evidence submitted — not on whether the medicine is legitimate or commonly prescribed.
What this means for your prescription
If a medicine you've been prescribed comes up at full price, it doesn't mean something has gone wrong — it usually just means that particular medicine, brand or use case sits outside the current PBS list. Your doctor is the right person to talk to about why a medicine was prescribed and whether a PBS-listed alternative exists for your situation; we simply price and dispense according to the schedule as it stands.
This article is general health information, not medical or financial advice. For advice about your own prescriptions, PBS eligibility or treatment options, speak with your doctor or pharmacist.
Frequently asked questions
Does a medicine being non-PBS mean it's lower quality or not properly regulated?+
No. PBS listing is a funding decision, not a quality or safety assessment. Non-PBS medicines sold in Australia are still registered or listed medicines regulated under the same framework as PBS-listed ones.
Why are ED medicines almost never PBS-subsidised?+
Erectile dysfunction medicines are generally treated by the scheme as outside the categories prioritised for broad public subsidy, aside from a small number of narrow, specific-circumstance listings. Most patients pay the full retail price, which is why generic versions matter for affordability.
Can a non-PBS medicine become PBS-listed later?+
Yes — manufacturers can apply (or reapply) to PBAC at any time, and listings do change over time as new cost-effectiveness evidence is submitted and assessed. There's no way to predict if or when that might happen for a particular medicine or brand.
Kamagra AUS Health Editorial Team
Plain-English health writing from our in-house editorial team — pharmacist-reviewed, focused on how Australians actually access and use medicines safely.
Mentioned in this guide
Shop the treatments covered here
Genuine medicines from the guide above — discreetly delivered Australia-wide.
